Showing results (91-100 of 2,396) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|March 29, 2008
Is triple negative a prognostic factor in breast cancer?Reiki Nishimura, Nobuyuki Arima
Breast Cancer (Tokyo, Japan)|April 10, 2025
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)Rurina Watanuki, Hitomi Sakai, Yuri Takehara, et al.
Breast Cancer (Tokyo, Japan)|May 6, 2025
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancerKazuhiro Kakimi, Tomoharu Sugie
Breast Cancer (Tokyo, Japan)|May 3, 2025
Polymorphous adenocarcinoma-like tumor of the breast: the first case report from JapanYuki Hara, Puay Hoon Tan, Maria Pia Foschini, et al.
Breast Cancer (Tokyo, Japan)|May 22, 2025
The impact of adjuvant radiotherapy on borderline and malignant phyllodes tumors of the breastAmonthep Charoenyothakun, Kanjana Shotelersuk, Chonnipa Nantavithya, et al.
Breast Cancer (Tokyo, Japan)|May 13, 2025
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocolTakeshi Ushigusa, Nami Hirakawa, Naoki Kanomata
Breast Cancer (Tokyo, Japan)|May 8, 2025
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validityTakahiro Tsukioki, Nozomu Takata, Saya R Dennis, et al.
Breast Cancer (Tokyo, Japan)|February 9, 2026
Presenteeism in working-age breast cancer survivors 1-5 years after surgery: relative contributions of treatment-related symptoms and modifiable factorsMasahiro Manfuku, Ryota Imai, Satoko Yono, et al.
Breast Cancer (Tokyo, Japan)|January 24, 2026
Real world experience of intraoperative radiation therapy (IORT) during lumpectomy for early-stage breast cancer: retrospective data from a single large institutional observational studyChristophe Scherer, Vivien Fung, Dimitri Anzellini, et al.
Breast Cancer (Tokyo, Japan)|May 7, 2013
Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancerTatsuya Yoshioka, Mitsuchika Hosoda, Mitsugu Yamamoto, et al.
Pageof 240